MarketLens

What Does NRx Pharmaceuticals' Recent $22.3 Million Offering Mean for Investors

2 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Does Hitek Global's Recent $8 Million Offering Mean for Investors

2 months ago

What Does Getty Realty's $131 Million Stock Offering Mean for Investors

6 months ago

What Does BriaCell's Latest Offering Mean for Investors

2 months ago

What Does EPRT's Latest Debt Offering Mean for Investors

2 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q2 2026 Earnings Call Transcript

NRx Pharmaceuticals reported Q2 2026 results, with financial performance and operational updates detailed in the earnings call. The company highlighted progress on key programs, though specific figure...

NRXP

Stock News•1 week ago

American Healthcare REIT Announces Pricing of Public Offering of Common Stock

American Healthcare REIT priced a 13.25M-share public offering, expected to raise ~$712.2M gross, closing August 12, 2026, via forward sale agreements.

AHR

Stock News•1 week ago

NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles

NRx Pharmaceuticals cleared the first-cycle FDA review of its ANDA for preservative-free ketamine, with one remaining issue tied to the vial connector. A final decision now hinges on resolving that it...

NRXP

Stock News•1 months ago

NanoViricides Announces Pricing of ~$3.8 Million Registered Direct Offering

NanoViricides raised ~$3.8M via a registered direct offering of 2.5M shares and warrants to a single institutional investor, diluting existing holders.

NNVC